163 related articles for article (PubMed ID: 10082109)
1. Outcome and safety of transrectal US-guided percutaneous cryotherapy for localized prostate cancer.
Saliken JC; Donnelly BJ; Brasher P; Ali-Ridha N; Ernst S; Robinson J
J Vasc Interv Radiol; 1999 Feb; 10(2 Pt 1):199-208. PubMed ID: 10082109
[TBL] [Abstract][Full Text] [Related]
2. Focal cryosurgical ablation of the prostate: a single institute's perspective.
Hale Z; Miyake M; Palacios DA; Rosser CJ
BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
[TBL] [Abstract][Full Text] [Related]
3. Cryosurgery as a treatment for prostate carcinoma: results and complications.
Wong WS; Chinn DO; Chinn M; Chinn J; Tom WL; Tom WL
Cancer; 1997 Mar; 79(5):963-74. PubMed ID: 9041159
[TBL] [Abstract][Full Text] [Related]
4. Rationale for a "male lumpectomy," a prostate cancer targeted approach using cryoablation: results in 21 patients with at least 2 years of follow-up.
Onik G
Cardiovasc Intervent Radiol; 2008; 31(1):98-106. PubMed ID: 17593431
[TBL] [Abstract][Full Text] [Related]
5. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years.
Bahn D; de Castro Abreu AL; Gill IS; Hung AJ; Silverman P; Gross ME; Lieskovsky G; Ukimura O
Eur Urol; 2012 Jul; 62(1):55-63. PubMed ID: 22445223
[TBL] [Abstract][Full Text] [Related]
6. Cryosurgery as primary treatment for localized prostate cancer.
Lian H; Guo H; Gan W; Li X; Yan X; Wang W; Yang R; Qu F; Ji C
Int Urol Nephrol; 2011 Dec; 43(4):1089-94. PubMed ID: 21475948
[TBL] [Abstract][Full Text] [Related]
7. Cryosurgery as primary treatment for localized prostate cancer: a community hospital experience.
Ellis DS
Urology; 2002 Aug; 60(2 Suppl 1):34-9. PubMed ID: 12206846
[TBL] [Abstract][Full Text] [Related]
8. [Preliminary results of the treatment of 44 patients with localized cancer of the prostate using transrectal focused ultrasound].
Gelet A; Chapelon JY; Bouvier R; Pangaud C; Souchon R; Blanc E; Cathignol D; Dubernard JM
Prog Urol; 1998 Feb; 8(1):68-77. PubMed ID: 9533155
[TBL] [Abstract][Full Text] [Related]
9. Transrectal ultrasound-guided transperineal cryoablation in the treatment of prostate carcinoma: preliminary results.
Wieder J; Schmidt JD; Casola G; vanSonnenberg E; Stainken BF; Parsons CL
J Urol; 1995 Aug; 154(2 Pt 1):435-41. PubMed ID: 7541861
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance imaging-guided cryoablation of recurrent prostate cancer after radical prostatectomy: initial single institution experience.
Woodrum DA; Kawashima A; Karnes RJ; Davis BJ; Frank I; Engen DE; Gorny KR; Felmlee JP; Callstrom MR; Mynderse LA
Urology; 2013 Oct; 82(4):870-5. PubMed ID: 23910089
[TBL] [Abstract][Full Text] [Related]
11. Single center experience with third-generation cryosurgery for management of organ-confined prostate cancer: critical evaluation of short-term outcomes, complications, and patient quality of life.
Hubosky SG; Fabrizio MD; Schellhammer PF; Barone BB; Tepera CM; Given RW
J Endourol; 2007 Dec; 21(12):1521-31. PubMed ID: 18186694
[TBL] [Abstract][Full Text] [Related]
12. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
Stock RG; Stone NN; DeWyngaert JK; Lavagnini P; Unger PD
Cancer; 1996 Jun; 77(11):2386-92. PubMed ID: 8635111
[TBL] [Abstract][Full Text] [Related]
13. [Ultrasound-guided cryosurgery of the prostate: short- and long-term experience].
Minardi D; Polito M; Galosi AB; Yehia M; Dellabella M; Lugnani F; Muzzonigro G
Arch Ital Urol Androl; 2000 Dec; 72(4):270-5. PubMed ID: 11221053
[TBL] [Abstract][Full Text] [Related]
14. Prostatic cryosurgery: use of MR imaging in evaluation of success and technical modifications.
Vellet AD; Saliken J; Donnelly B; Raber E; McLaughlin RF; Wiseman D; Ali-Ridha NH
Radiology; 1997 Jun; 203(3):653-9. PubMed ID: 9169684
[TBL] [Abstract][Full Text] [Related]
15. Cryoablation for clinically localized prostate cancer using an argon-based system: complication rates and biochemical recurrence.
De La Taille A; Benson MC; Bagiella E; Burchardt M; Shabsigh A; Olsson CA; Katz AE
BJU Int; 2000 Feb; 85(3):281-6. PubMed ID: 10671882
[TBL] [Abstract][Full Text] [Related]
16. Prospective Outcome Analysis of the Safety and Efficacy of Partial and Complete Cryoablation in Organ-confined Prostate Cancer.
Barqawi AB; Huebner E; Krughoff K; O'Donnell CI
Urology; 2018 Feb; 112():126-131. PubMed ID: 29126844
[TBL] [Abstract][Full Text] [Related]
17. Post-operative serial prostate-specific antigen and transrectal ultrasound for staging incidental carcinoma of the prostate.
Feneley MR; Webb JA; McLean A; Kirby RS
Br J Urol; 1995 Jan; 75(1):14-20. PubMed ID: 7531587
[TBL] [Abstract][Full Text] [Related]
18. Positive resection margin and/or pathologic T3 adenocarcinoma of prostate with undetectable postoperative prostate-specific antigen after radical prostatectomy: to irradiate or not?
Choo R; Hruby G; Hong J; Hong E; DeBoer G; Danjoux C; Morton G; Klotz L; Bhak E; Flavin A
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):674-80. PubMed ID: 11849789
[TBL] [Abstract][Full Text] [Related]
19. Focal prostate cryoablation: initial results show cancer control and potency preservation.
Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
[TBL] [Abstract][Full Text] [Related]
20. Cryosurgical ablation of the prostate: two-year prostate-specific antigen and biopsy results.
Cohen JK; Miller RJ; Rooker GM; Shuman BA
Urology; 1996 Mar; 47(3):395-401. PubMed ID: 8633408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
